Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
NESINA MET 12.5/850; 12.5 mg alogliptin (as benzoate) / 850 mg metformin hydrochloride film-coated tablets blister pack, Takeda Pharmaceuticals Australia Pty Ltd, CON-412
Product name
NESINA MET 12.5/850; 12.5 mg alogliptin (as benzoate) / 850 mg metformin hydrochloride film-coated tablets blister pack
Sponsor name
Takeda Pharmaceuticals Australia Pty Ltd
Consent start
Consent no.
CON-412
Standard
Paragraph 8(1)(i) in the Therapeutic Goods Order No. 91 -Standard for labels of prescription and related medicines
Non-compliance with standard
Do not include the current address of the sponsor on the labels.
Therapeutic product type
Prescription medicines